Trials / Completed
CompletedNCT02693613
Pharmacokinetic Study of ASP1517 With Kremezin®
Pharmacokinetic Study of ASP1517 - Evaluation of the Effect of Kremezin® on the Pharmacokinetics of ASP1517 in Non-elderly Healthy Adult Male Subjects, When Administered Concomitantly or in a Time Separated Manner.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- Male
- Age
- 20 Years – 44 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to evaluate the effect of Kremezin® on the pharmacokinetics of single dose of ASP1517 in healthy non-elderly adult male subjects when administered concomitantly or in a time separated manner.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASP1517 | Oral |
| DRUG | Kremezin® | Oral |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2016-02-29
- Last updated
- 2016-06-21
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02693613. Inclusion in this directory is not an endorsement.